Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Mannkind Corp (NASDAQ:MNKD)

Tuesday’s Trading Day
0.97 +0.0967 / +11.07%
As of Feb 09
Day’s Change
Wednesday’s Pre-Market   Switch to standard view »
0.9698 -0.0002 / -0.02%
 
Volume: 42.2K

Today’s Trading

Previous close0.87
Today’s open0.88
Day’s range0.85 - 1.00
Volume4,772,438
Average volume (3 months)7,270,890
Market cap$415.8M
Dividend yield--
Data as of 02/09/2016

Growth & Valuation

Earnings growth (last year)+20.31%
Earnings growth (this year)+46.50%
Earnings growth (next 5 years)+26.80%
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book--

Competitors

 Today’s
change
Today’s
% change
CORTCorcept Therapeutics...+0.06+1.74%
SVASinovac Biotech Ltd-0.12-1.79%
ARRYArray Biopharma Inc-0.12-4.58%
FLMLFlamel Technologies ...+0.06+0.65%
Data as of 02/09/2016

Financials

Next reporting dateFebruary 16, 2016
EPS forecast (this quarter)-$0.05
Annual revenue (last year)$0.00
Annual profit (last year)-$198.4M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
CEO, CFO, Director, VP &
Head-Investor Relations
Matthew J. Pfeffer
Chief Operating Officer
Juergen A. Martens
Corporate headquarters
Valencia, California

Forecasts

Partner Offers